Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04834024
Status:
RECRUITING
Last Update Posted:
2023-10-23
First Post:
2021-04-05
Brief Title:
MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma
Sponsor:
Organization:
Beijing Mabworks Biotech Co Ltd